Tessera Defense and Homeland Security (HLSQ) vs Scinai Immunotherapeutics (SCNI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Tessera Defense and Homeland Security is the larger company by market cap ($2.6 million vs $1.6 million), about 1.6 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | HLSQ | SCNI |
|---|---|---|
| Share price | $0.285 | $1.18 |
| Market cap | $2.57M | $1.60M |
| 1-day change | -2.23% | -2.48% |
| P/E ratio (TTM) | — | 0.04 |
| EPS (TTM) | $-160.60 | $28.07 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $122.93 | $15.65 |
| 52-week low | $0.263 | $1.06 |
| Distance from 52-week high | -99.77% | -92.46% |
| Average volume | 640.26K | 1.10M |
| Shares outstanding | 9.03M | 1.35M |
| Employees | 20 | 45 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Tessera Defense and Homeland Security
HLSQ stock →Tessera Defense and Homeland Security Inc. develops and provides defense, homeland security, and critical infrastructure technologies.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 20 employees
About Scinai Immunotherapeutics
SCNI stock →Scinai Immunotherapeutics Ltd., together with its subsidiaries, operates as a biopharmaceutical company in Israel and internationally. It engages in the research and development of IL-17 NanoAb, a VHH-based antibody platform for the treatment of immune-mediated and inflammatory diseases, including psoriasis; and PC111, a human monoclonal antibody for the treatment of pemphigus, Steven Johnson's syndrome, and toxic epidermal necrolysis.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 45 employees
HLSQ vs SCNI FAQ
Which is bigger, Tessera Defense and Homeland Security or Scinai Immunotherapeutics?
Tessera Defense and Homeland Security (HLSQ) is larger, with a market capitalization of $2.57M compared with $1.60M for Scinai Immunotherapeutics (SCNI).
Are Tessera Defense and Homeland Security and Scinai Immunotherapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.